Ovarian Cancer Risk at Age 32: Statistics, Factors, and Vigilance

Ovarian cancer is uncommon under 35 (~5% of cases <40).

Risk Context

• Lifetime risk (US women): ~1.3% (1 in 78).
• Age-specific incidence: Rises sharply after 50; peak 60s–70s.
• At 32: Annual incidence ~4–5 per 100,000.

Risk Modifiers

• Increased: BRCA1/2, Lynch syndrome, family history, endometriosis, nulliparity, early menarche/late menopause.
• Decreased: OCPs (≥5 yrs → 50% reduction), pregnancy, breastfeeding, tubal ligation, hysterectomy.

Symptoms (Often Vague, Late)

• Bloating, pelvic/abdominal pain
• Early satiety, urinary urgency
• Fatigue, menstrual changes

Screening

• No effective population screening (CA-125 + TVUS not mortality-reducing in average risk).
• High-risk (BRCA+): consider risk-reducing salpingo-oophorectomy (RRSO) at 35–45.

Discuss family history with provider; genetic counseling if indicated.